balance equationreview2025-10-31
Difference 1865000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
Revenue
$66.32M
Fiscal year ended 2026-07-31Operating income
$3.16M
Fiscal year ended 2026-07-31Free cash flow
Unavailable
Fiscal year ended 2026-07-31KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported revenue of $66.32M and net income of $1.71M for the fiscal year ended 2026-07-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from KEWAUNEE SCIENTIFIC CORP /DE/’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $66.32M | $71.40M | $69.40M | $70.10M | $71.10M | $77.15M | $67.17M | $47.76M | $48.39M | $56.70M |
| Cost of revenue | $46.68M | $50.16M | $50.85M | $50.38M | $50.17M | $53.11M | $48.79M | $33.81M | $35.90M | $42.06M |
| Gross profit | $19.64M | $21.24M | $18.54M | $19.72M | $20.93M | $24.04M | $18.38M | $13.95M | $12.49M | $14.64M |
| Operating income | $3.16M | $5.22M | $2.58M | $4.11M | $4.81M | $8.50M | $2.25M | $4.43M | $2.58M | $5.56M |
| Net income | $1.71M | $3.39M | $692.00K | $2.44M | $3.09M | $4.85M | $1.35M | $3.01M | $2.19M | $11.03M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 2.92M | Unavailable | shares 2.98M | shares 2.99M | shares 2.96M | Unavailable | shares 3.00M | shares 2.97M | shares 2.97M | Unavailable |
| Pretax income | $2.56M | $4.76M | $1.60M | $3.45M | $3.92M | $7.15M | $1.28M | $3.93M | $2.43M | $1.35M |
| Income tax expense | $717.00K | $1.06M | $528.00K | $915.00K | $761.00K | $2.20M | -$108.00K | $916.00K | $192.00K | -$9.83M |
| Diluted EPS | $0.58 | Unavailable | $0.23 | $0.82 | $1.04 | Unavailable | $0.45 | $1.01 | $0.74 | Unavailable |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $8.25M | $9.95M | $8.15M | $12.59M | $19.49M | $14.94M | $9.45M | $25.96M | $24.21M | $23.27M |
| Total assets | $175.80M | $178.31M | $175.96M | $189.08M | $193.49M | $194.65M | $189.15M | $134.48M | $132.02M | $134.77M |
| Current assets | $103.95M | $105.40M | $103.58M | $113.64M | $117.15M | $118.36M | $108.61M | $96.44M | $92.70M | $96.82M |
| Total liabilities | $98.58M | $101.50M | $103.43M | $117.36M | $124.62M | $128.41M | $127.03M | $73.82M | $74.50M | $78.56M |
| Current liabilities | $47.24M | $48.35M | $48.78M | $45.81M | $50.49M | $53.71M | $50.17M | $36.47M | $36.69M | $40.78M |
| Total equity incl. NCI | $77.22M | $76.81M | $72.53M | $69.85M | $67.08M | $64.46M | $60.80M | $59.33M | $56.02M | $54.76M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $29.79M | $30.53M | $32.91M | $35.50M | $34.92M | $32.85M | $31.56M | $18.66M | $19.28M | $20.68M |
| Accounts receivable | $58.20M | $58.74M | $54.13M | $59.02M | $56.90M | $62.38M | $57.42M | $41.88M | $43.54M | $45.06M |
| Goodwill | $12.49M | $12.49M | $12.49M | $12.49M | $12.49M | $12.49M | $14.15M | Unavailable | Unavailable | $0 |
| Long-term debt | $13.83M | $15.08M | $16.33M | $32.25M | $34.38M | $34.68M | $34.96M | Unavailable | Unavailable | Unavailable |
| Accounts payable | $21.56M | $22.46M | $23.64M | $22.66M | $26.33M | $27.03M | $24.53M | $21.46M | $20.62M | $23.26M |
Cash flow
| Metric | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.98M | $5.46M | $11.65M | -$4.26M | $5.79M | $9.41M | -$2.27M | $8.44M | -$794.00K | $1.14M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$772.00K | -$928.00K | -$668.00K | -$1.57M | -$771.00K | -$516.00K | -$29.42M | -$683.00K | -$278.00K | -$979.00K |
| Financing cash flow | -$2.50M | -$2.95M | -$14.06M | -$853.00K | -$1.46M | -$4.34M | $14.64M | -$3.23M | $343.00K | -$1.47M |
| Net change in cash | -$1.36M | $1.27M | -$3.33M | -$6.76M | $3.28M | $4.83M | -$17.33M | $4.48M | -$752.00K | -$1.17M |
| Stock-based compensation | $1.90M | $502.00K | $542.00K | $561.00K | $521.00K | $370.00K | $380.00K | $373.00K | $318.00K | $363.00K |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $529.00K | Unavailable | Unavailable | Unavailable | $0 | $1.60M | Unavailable | Unavailable | Unavailable | $1.21M |
| Depreciation & amortization | $1.59M | $1.56M | $1.60M | $1.58M | $1.55M | $1.58M | $1.56M | $806.00K | $815.00K | Unavailable |
Derived
| Metric | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 29.6% | 29.8% | 26.7% | 28.1% | 29.4% | 31.2% | 27.4% | 29.2% | 25.8% | 25.8% |
| Operating margin | 4.8% | 7.3% | 3.7% | 5.9% | 6.8% | 11.0% | 3.3% | 9.3% | 5.3% | 9.8% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 2.9% | 0.7% | 0.8% | 0.8% | 0.7% | 0.5% | 0.6% | 0.8% | 0.7% | 0.6% |
| Current ratio | 2.20x | 2.18x | 2.12x | 2.48x | 2.32x | 2.20x | 2.16x | 2.64x | 2.53x | 2.37x |
| Revenue YoY growth | -6.7% | -7.5% | 3.3% | 46.8% | 46.9% | 36.1% | 43.6% | -5.3% | -2.9% | 5.0% |
| Net margin | 2.6% | 4.7% | 1.0% | Unavailable | 4.3% | 6.3% | 2.0% | Unavailable | Unavailable | 19.4% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 0.18x | 0.20x | 0.23x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 28.0% | 22.4% | 32.9% | 26.5% | 19.4% | 30.8% | -8.5% | 23.3% | 7.9% | -729.9% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open KEQU in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-09-11View SEC filing
10-K · Filed 2026-06-26View SEC filing
10-Q · Filed 2026-03-13View SEC filing
10-Q · Filed 2025-12-12View SEC filing
10-Q · Filed 2025-09-12View SEC filing
10-K · Filed 2025-07-02View SEC filing
Reconciliation checks needing review
11 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2025-07-31
Difference 1791000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2025-04-30
Difference 1788000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2025-01-31
Difference 1320000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2024-10-31
Difference 1329000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2024-07-31
Difference 1490000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2024-04-30
Difference 1449000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2024-01-31
Difference 1259000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2023-10-31
Difference 1306000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2023-07-31
Difference 1110000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2023-04-30
Difference 1076000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.